CIG vs RYTM Comparison

Cia Energetica DE Minas Gerais - Cemig is a Brazilian energy company engaged in the generation, transmission, distribution, and commercialization of electricity, as well as natural gas distribution. The company operates through six segments: Generation, Transmission, Trading, Distribution, Gas, and Investees. Its activities include power generation mainly from hydroelectric sources, operation and maintenance of transmission and distribution infrastructure, electricity sales to captive and free-market customers, and gas distribution in Minas Gerais. The company derives a majority of its revenue from the Distribution segment, which comprises the distribution and sale of electricity to captive customers, and the operation and maintenance of infrastructure and related services.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.